Evaluation of the 4th Generation QuantiFERON-TB Test (QFT-Plus) for the Detection of Tuberculosis Infection



Status:Recruiting
Conditions:Infectious Disease
Therapuetic Areas:Immunology / Infectious Diseases
Healthy:No
Age Range:18 - 80
Updated:4/5/2017
Start Date:October 2015
End Date:December 2017
Contact:Ashley Knights, PhD.
Email:ashley.knights@qiagen.com
Phone:(301) 944-7108

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
To compare the positivity rate of the investigational assay to the currently approved
QuantiFERON-TB Gold In-Tube assay.


Low Risk and Known Risk Cohorts

Inclusion Criteria:

- Compensated and uncompensated members (current or future) of the Department of
Veterans Affairs with no identified symptoms of active TB disease

- Age greater than 18 years or less than 80 years.

Exclusion Criteria:

- Currently taking therapy for active tuberculosis or latent TB infection for more than
14 days.
We found this trial at
1
site
VA Palo Alto Health Care System (VAPAHCS)
Palo Alto, California 94304
Principal Investigator: Mark Holodniy, MD
Phone: 650-852-3408
?
mi
from
Palo Alto, CA
Click here to add this to my saved trials